...
首页> 外文期刊>Surgical Endoscopy >Incorporating patient-preference evidence into regulatory decision making
【24h】

Incorporating patient-preference evidence into regulatory decision making

机译:将患者偏爱的证据纳入监管决策

获取原文
获取原文并翻译 | 示例
           

摘要

Background Patients have a unique role in deciding what treatments should be available for them and regulatory agencies should take their preferences into account when making treatment approval decisions. This is the first study designed to obtain quantitative patient-preference evidence to inform regulatory approval decisions by the Food and Drug Administration Center for Devices and Radiological Health.
机译:背景患者在决定应为他们提供何种治疗方法方面扮演着独特的角色,管理机构在做出治疗批准决定时应考虑他们的偏好。这是第一项旨在获得定量患者偏爱证据以告知食品和药物管理局药品和放射卫生管理中心法规批准决定的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号